Associations between Patients' Demographics and Chronic Medication Utilization in Internal Medicine: Cross-sectional

Fatema Alrashed1, Mohammad Shehab2,3

  • 1Department of Pharmacy Practice, College of Pharmacy, Kuwait University, Jabrya, Kuwait.

Insights

Age significantly impacts chronic medication use, particularly for conditions like hypertension and dyslipidemia. Gender showed a lesser effect on medication patterns in this study of 501 patients.

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Public Health

Background:

  • Chronic diseases like diabetes, dyslipidemia, and hypertension are leading global health burdens.
  • Effective pharmacological management is essential for controlling these conditions.
  • Demographic factors may influence medication utilization patterns.

Purpose of the Study:

  • To investigate the association between patient demographics (age and gender) and the utilization of chronic medications.
  • To provide data for informed policy decisions and future research in chronic disease management.

Main Methods:

  • Retrospective cross-sectional study of 501 adult patients with chronic conditions.
  • Data collected from electronic medical records over 12 months (September 2023 - September 2024).
  • Chi-square test used to analyze associations between demographics and medication classes.

Main Results:

  • Age was significantly associated with the use of antihypertensives, lipid-lowering agents, and anticoagulants (P < 0.001).
  • Gender showed minimal impact, with a significant association only for antiplatelet use in males (P = 0.0001).
  • The cohort comprised 54.1% females with a mean age of 64 years.

Conclusions:

  • Age is a significant factor influencing chronic medication prescription in secondary care.
  • Gender has a limited role in determining chronic medication use compared to age.
  • Findings highlight the importance of demographic considerations in chronic disease pharmacotherapy.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
10.7K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
156
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181